• Chiropractor Dan Ourada from Clarendon Hills, IL, is on probation for falsely advertising thermography as a breast cancer detection tool.
• The Illinois Department of Financial and Professional Regulations required Ourada to post disclaimers on his website about thermography's limitations.
• Ourada's probation requires him to acknowledge that thermography is not a replacement for mammography and lacks FDA support for breast cancer screening.

Dan Ourada, a chiropractor from Clarendon Hills, Illinois, has been placed on professional probation following allegations of making false claims about thermography, a procedure he advertised on his website as a method for detecting breast cancer. The Illinois Department of Financial and Professional Regulations took action after determining that Ourada's claims were misleading and lacked scientific support. The consent decree mandates that Ourada include specific disclaimers on his website about the limitations of thermography in breast cancer screening.

• What: A chiropractor, Dan Ourada, made false claims about the ability of thermography to detect breast cancer, leading to a consent decree and professional probation.
• Who: Dan Ourada, Illinois Department of Financial and Professional Regulations, American Cancer Society, American College of Radiology, FDA.
• When: Consent decree signed in February 2025; probation for one year.
• Where: Clarendon Hills and Lisle, Illinois (Ourada's practice location).

The case highlights the importance of regulating health claims made by practitioners, particularly concerning cancer detection. The Illinois Department of Financial and Professional Regulations' action demonstrates a commitment to protecting the public from misleading or unsubstantiated medical information. The required disclaimers aim to ensure that patients are aware of the limitations of thermography and do not rely on it as a primary screening tool for breast cancer.

Dan Ourada, a chiropractor in Clarendon Hills, is serving a year of professional probation for making false claims about thermography's ability to detect breast cancer. The Illinois Department of Financial and Professional Regulations has mandated specific disclaimers on his website to inform patients about the procedure's limitations. This case underscores the regulatory scrutiny of health claims and the importance of accurate information in healthcare.